TY - JOUR
T1 - Features and clinical implications of fasting intact proinsulin to insulin molar (P/I) ratio 2
T2 - Analysis on the correlation between P/I ratio and each factor in the type 2 diabetes mellitus
AU - Kawazu, Shoji
AU - Yazawa, Masako
AU - Imai, Yasuo
AU - Horie, Hitoshi
AU - Hisano, Yoshikazu
AU - Koyama, Yuhei
AU - Ishida, Hitoshi
AU - Ozawa, Sachihiko
AU - Suzuki, Kiyoshi
AU - Iwamoto, Yasuhiko
AU - Sakura, Hiroshi
AU - Kanazawa, Yasunori
AU - Kawamori, Ryuzo
AU - Uchino, Hiroshi
AU - Kobayashi, Tetsuro
AU - Aida, Kaoru
AU - Tomono, Shoichi
AU - Nagasaka, Shoichiro
AU - Matsuba, Ikuro
AU - Maruyama, Taro
AU - Saisho, Yoshifumi
AU - Kuzuya, Takeshi
PY - 2009
Y1 - 2009
N2 - We examined the characteristics of plasma intact proinsulin to insulin molar (P/I) ratio at fasting in the morning, using type 2 diabetic patients. P/I ratio showed a significant correlation with HOMA-β and Insulinogenic Index. In multivariate analysis, fasting plasma insulin was well associated with BMI, and intact proinsulin was associated with BMI and fasting plasma glucose. On the other hand, P/I ratio was associated with duration of diabetes in addition to the above. P/I ratio of the patients who were positive for family history showed significantly higher value than the non-family history group. Moreover, P/I ratio of the patients with diabetic complications showed significantly higher value than the non-complication group. Furthermore, P/I ratio of glibenclamide or glimepiride group, were significantly higher than that of the diet group. These results suggest that P/I ratio could be useful to understand pancreatic β cell dysfunction in type 2 diabetes mellitus, either for estimating the stage of diabetes or titrating the optimal drug therapy.
AB - We examined the characteristics of plasma intact proinsulin to insulin molar (P/I) ratio at fasting in the morning, using type 2 diabetic patients. P/I ratio showed a significant correlation with HOMA-β and Insulinogenic Index. In multivariate analysis, fasting plasma insulin was well associated with BMI, and intact proinsulin was associated with BMI and fasting plasma glucose. On the other hand, P/I ratio was associated with duration of diabetes in addition to the above. P/I ratio of the patients who were positive for family history showed significantly higher value than the non-family history group. Moreover, P/I ratio of the patients with diabetic complications showed significantly higher value than the non-complication group. Furthermore, P/I ratio of glibenclamide or glimepiride group, were significantly higher than that of the diet group. These results suggest that P/I ratio could be useful to understand pancreatic β cell dysfunction in type 2 diabetes mellitus, either for estimating the stage of diabetes or titrating the optimal drug therapy.
UR - http://www.scopus.com/inward/record.url?scp=70350158365&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70350158365&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:70350158365
SN - 0021-437X
VL - 52
SP - 547
EP - 554
JO - Journal of the Japan Diabetes Society
JF - Journal of the Japan Diabetes Society
IS - 7
ER -